Susquehanna International Group, LLP Aptinyx Inc. Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.27 - $3.62 $47,681 - $76,038	-21,005 Reduced 8.63%	222,270 $505,000
Q4 2021 Feb 14, 2022	BUY	$2.11 - $3.0 $185,977 - $264,423	88,141 Added 56.82%	243,275 $650,000
Q3 2021 Nov 15, 2021	BUY	$2.21 - $2.89 $208,520 - $272,680	94,353 Added 155.23%	155,134 $363,000
Q2 2021 Aug 11, 2021	BUY	$2.39 - $3.5 $66,504 - $97,391	27,826 Added 84.44%	60,781 $172,000
Q1 2021 May 17, 2021	SELL	$2.86 - $4.33 $62,625 - $94,814	-21,897 Reduced 39.92%	32,955 $99,000
Q4 2020 Feb 16, 2021	BUY	$2.93 - $4.3 $160,716 - $235,863	54,852 New	54,852 $190,000
Q2 2020 Aug 14, 2020	SELL	$1.99 - $4.4 $309,667 - $684,692	-155,612 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.81 - $5.03 $254,011 - $705,900	140,338 Added 918.8%	155,612 $336,000
Q4 2019 Feb 14, 2020	BUY	$2.84 - $4.25 $43,378 - $64,914	15,274 New	15,274 $52,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.